Sirigen Group

Healthcare diagnostics tools

Sirigen Group

Sector

Lifesciences

Location

Hampshire

Deal type

Growth Capital

Investment size

Undisclosed - 3.8x return

Investment date(s)

2010, 2011, 2012 - 2012

Website

The business

A portfolio of nine patents including Nobel Prize winning technology with a wide range of applications in research, medical diagnostics and life sciences
Highly experienced and entrepreneurial management team with a solid background in life sciences
Significant potential to dramatically improve market share in the $49bn diagnostics sector

The strategy

Relocate the pioneering technology operations from the USA to the UK and continue to invest in product development
Improve financial functions in the firm and commercialise the trademarked technology
Build strong strategic partnerships in the UK and USA to grow sales

The developments

Attracted a high calibre chair and non-executive director to the business
Successfully commercialised the product suite and integrated the technology into a range of products
Continued to grow the customer base worldwide
Sold to global medical technology firm Becton Dickinson in a $60m+ deal which delivered a 3.8x return for YFM funds

Back to top